These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32648245)

  • 81. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19.
    Pinky ; Gupta S; Krishnakumar V; Sharma Y; Dinda AK; Mohanty S
    Stem Cell Rev Rep; 2021 Feb; 17(1):33-43. PubMed ID: 32661867
    [TBL] [Abstract][Full Text] [Related]  

  • 82. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
    Verma YK; Verma R; Tyagi N; Behl A; Kumar S; Gangenahalli GU
    Stem Cell Rev Rep; 2021 Feb; 17(1):113-131. PubMed ID: 32920752
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19.
    Klimczak A
    World J Stem Cells; 2020 Sep; 12(9):1013-1022. PubMed ID: 33033561
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
    Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
    Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients.
    Esquivel D; Mishra R; Soni P; Seetharaman R; Mahmood A; Srivastava A
    Stem Cell Rev Rep; 2021 Feb; 17(1):144-152. PubMed ID: 32740890
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
    Gardin C; Ferroni L; Chachques JC; Zavan B
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32858940
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.
    Shu L; Niu C; Li R; Huang T; Wang Y; Huang M; Ji N; Zheng Y; Chen X; Shi L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J; Feng G
    Stem Cell Res Ther; 2020 Aug; 11(1):361. PubMed ID: 32811531
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.
    Meng F; Xu R; Wang S; Xu Z; Zhang C; Li Y; Yang T; Shi L; Fu J; Jiang T; Huang L; Zhao P; Yuan X; Fan X; Zhang JY; Song J; Zhang D; Jiao Y; Liu L; Zhou C; Maeurer M; Zumla A; Shi M; Wang FS
    Signal Transduct Target Ther; 2020 Aug; 5(1):172. PubMed ID: 32855385
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis.
    Li Z; Niu S; Guo B; Gao T; Wang L; Wang Y; Wang L; Tan Y; Wu J; Hao J
    Cell Prolif; 2020 Dec; 53(12):e12939. PubMed ID: 33098357
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
    Wang J; Zou W; Liu J
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.
    Yadav P; Vats R; Bano A; Bhardwaj R
    Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Safety and Effectiveness of Intravascular Mesenchymal Stem Cells to Treat Organ Failure and Possible Application in COVID-19 Complications.
    Atluri S; Manocha V; Boddu N; Bhati S; Syed Z; Diwan S; Manchikanti L
    Pain Physician; 2020 Aug; 23(4S):S391-S420. PubMed ID: 32942796
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review.
    Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N
    Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Can mesenchymal stem cells be used to treat COVID-19-induced pneumonia? (Review).
    Çetin İ; Topçul M
    Biomed Rep; 2020 Dec; 13(6):62. PubMed ID: 33194191
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mesenchymal stem cell treatment in a critically ill COVID-19 patient: a case report.
    Zengin R; Beyaz O; Koc ES; Akinci IO; Kocagoz S; Sagcan G; Ovali E; Cuhadaroglu C
    Stem Cell Investig; 2020; 7():17. PubMed ID: 33110915
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Stem Cell Therapy: A Promising Approach in Treatment of COVID-19.
    Abbaspanah B; Abroun S; Zarrabi M; Mozdgir A; Mollanouri M
    Curr Stem Cell Res Ther; 2021; 16(4):406-413. PubMed ID: 33045970
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients.
    Alzahrani FA; Saadeldin IM; Ahmad A; Kumar D; Azhar EI; Siddiqui AJ; Kurdi B; Sajini A; Alrefaei AF; Jahan S
    Stem Cells Int; 2020; 2020():8835986. PubMed ID: 33014070
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Stem Cells Secretome from Oral Tissue Could Represent a Promising Therapeutic Approach in COVID-19-Disease?
    Diomede F; Marconi GD; Fonticoli L; Pizzicannella J; Trubiani O
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957696
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia.
    Guo Z; Chen Y; Luo X; He X; Zhang Y; Wang J
    Crit Care; 2020 Jul; 24(1):420. PubMed ID: 32653043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.